Reaction Details Report a problem with these data
Target
B-cell lymphoma 6 protein [5-129]
Ligand
BDBM522205
Substrate
n/a
Meas. Tech.
HTRF Assay
IC50
89.1±n/a nM
Citation
 Bellenie, BR; Cheung, KM; Davis, OA; Hoelder, S; Huckvale, R; Lloyd, MG 2-quinolone derived inhibitors of BCL6 US Patent  US11161839 Publication Date 11/2/2021 
Target
Name:
B-cell lymphoma 6 protein [5-129]
Synonyms:
BCL5 | BCL6 | BCL6_HUMAN | BTB domain-containing protein 27 (BCL-6)(5-129) | LAZ3 | ZBTB27 | ZNF51
Type:
Enzyme Catalytic Domain
Mol. Mass.:
14310.07
Organism:
Homo sapiens (Human)
Description:
aa 5-129
Residue:
125
Sequence:
ADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASE
  
Inhibitor
Name:
BDBM522205
Synonyms:
US11161839, Example 3a
Type:
Small organic molecule
Emp. Form.:
C24H23ClN8O2
Mol. Mass.:
490.945
SMILES:
CC(Nc1cc(=O)n(C)c2ccc(Nc3ccnc(Cl)c3C#N)cc12)C(=O)NCc1cnn(C)c1
Structure:
Search PDB for entries with ligand similarity: